A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor
Clinical trial NCT07243340 · RECRUITING
Trial details
- NCT number
- NCT07243340
- Sponsor
- ImmVira Pharma Co. Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-03
- Primary completion
- 2027-12-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.